Scarica l'app Stockscreener
13.39
1.29%
-0.1753
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$13.57
Aprire:
$13.6
Volume 24 ore:
209.55K
Relative Volume:
0.26
Capitalizzazione di mercato:
$923.63M
Reddito:
$46.02M
Utile/perdita netta:
$-70.80M
Rapporto P/E:
-7.3597
EPS:
-1.82
Flusso di cassa netto:
$-1.61M
1 W Prestazione:
-1.65%
1M Prestazione:
+0.34%
6M Prestazione:
+148.98%
1 anno Prestazione:
+51.70%
Intervallo 1D:
$13.14
$13.76
Intervallo di 1 settimana:
$12.99
$14.36
Portata 52W:
$3.91
$14.91
Eyepoint Pharmaceuticals Inc Stock (EYPT) Company Profile
Nome
Eyepoint Pharmaceuticals Inc
Settore
Industria
Telefono
617-926-5000
Indirizzo
480 PLEASANT STREET, WATERTOWN, MA
Confronta EYPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EYPT
Eyepoint Pharmaceuticals Inc
|
13.40 | 935.35M | 46.02M | -70.80M | -1.61M | -1.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.02 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.17 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.91 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
808.23 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-07 | Iniziato | Citigroup | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-28 | Iniziato | Jefferies | Buy |
| 2024-01-22 | Iniziato | JP Morgan | Overweight |
| 2023-11-02 | Iniziato | Mizuho | Buy |
| 2023-04-21 | Iniziato | Robert W. Baird | Outperform |
| 2022-07-07 | Iniziato | Chardan Capital Markets | Buy |
| 2021-03-01 | Iniziato | Cowen | Outperform |
| 2021-01-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-04-06 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2019-11-04 | Ripresa | Laidlaw | Buy |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
Mostra tutto
Eyepoint Pharmaceuticals Inc Borsa (EYPT) Ultime notizie
EyePoint initiated at buy by Citi on wAMD drug potential - MSN
Will EyePoint Pharmaceuticals Inc. stock split attract more investors2025 Buyback Activity & Long Hold Capital Preservation Tips - newser.com
Chart based analysis of EyePoint Pharmaceuticals Inc. trends2025 Year in Review & Fast Gain Swing Trade Alerts - newser.com
Using R and stats models for EyePoint Pharmaceuticals Inc. forecastingQuarterly Earnings Report & Risk Managed Investment Strategies - newser.com
Is EyePoint Pharmaceuticals Inc. (PV3B) stock a buy before new product rolloutExit Point & Momentum Based Trading Ideas - newser.com
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Eyepoint Pharmaceuticals' (EYPT) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
How EyePoint Pharmaceuticals Inc. (PV3B) stock behaves in tightening cyclesVolume Spike & Advanced Technical Signal Analysis - newser.com
Is a relief rally coming for EyePoint Pharmaceuticals Inc. holdersJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
What downside risks could hit EyePoint Pharmaceuticals Inc. (PV3B) stock2025 Market Trends & Low Drawdown Investment Ideas - newser.com
Using Bollinger Bands to evaluate EyePoint Pharmaceuticals Inc.2025 EndofYear Setup & Verified Chart Pattern Signals - newser.com
What analysts say about EyePoint Pharmaceuticals Inc stockReal-Time Stock Alerts & Take Advantage of Momentum Stocks - earlytimes.in
EyePoint Pharmaceuticals Hits New 52-Week High of $14.90 - Markets Mojo
Can EyePoint Pharmaceuticals Inc. (PV3B) stock sustain margin levelsCEO Change & Daily Stock Trend Reports - newser.com
Candlestick signals on EyePoint Pharmaceuticals Inc. stock todayQuarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Published on: 2025-10-03 02:01:33 - newser.com
Sentiment analysis tools applied to EyePoint Pharmaceuticals Inc.Trade Volume Summary & Low Drawdown Momentum Ideas - newser.com
Mizuho Securities Maintains EyePoint Pharmaceuticals(EYPT.US) With Buy Rating, Maintains Target Price $28 - 富途牛牛
EyePoint stock rating reiterated at Outperform by Mizuho amid competitor review - Investing.com
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Hits New 1-Year HighHere's Why - MarketBeat
EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Up 4%Time to Buy? - MarketBeat
Detecting support and resistance levels for EyePoint Pharmaceuticals Inc.July 2025 Market Mood & Momentum Based Trading Ideas - newser.com
Published on: 2025-09-29 08:12:16 - newser.com
Will earnings trigger a reversal in EyePoint Pharmaceuticals Inc.Portfolio Return Report & Detailed Earnings Play Alerts - newser.com
What analysts say about EyePoint Pharmaceuticals Inc PV3B stockLong-Term Investment Plans & Low Cost Wealth Building - earlytimes.in
Biotech Stocks Rally. 3 Favorite Plays From the Charts. - Barron's
Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Published on: 2025-09-22 08:23:21 - خودرو بانک
Published on: 2025-09-20 23:35:30 - خودرو بانک
Death Cross: What are analysts price targets for EyePoint Pharmaceuticals IncTrade Exit Summary & Reliable Price Action Trade Plans - خودرو بانک
Sentiment Review: Can EyePoint Pharmaceuticals Inc. outperform under higher oil pricesPortfolio Return Report & Fast Entry and Exit Trade Plans - خودرو بانک
Is EyePoint Pharmaceuticals (NASDAQ:EYPT) In A Good Position To Invest In Growth? - Yahoo Finance
EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Exploring A 150% Potential Upside - DirectorsTalk Interviews
Eyepoint Pharmaceuticals Inc Azioni (EYPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Eyepoint Pharmaceuticals Inc Azioni (EYPT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Lurker Nancy | Director |
Jul 10 '25 |
Option Exercise |
0.00 |
11,111 |
0 |
216,547 |
| Duker Jay S. | President and CEO |
Jul 10 '25 |
Option Exercise |
0.00 |
16,667 |
0 |
17,653 |
| Elston George | Chief Financial Officer |
May 25 '25 |
Option Exercise |
0.00 |
7,500 |
0 |
83,050 |
| Zaderej Karen L. | Director |
May 19 '25 |
Buy |
5.99 |
5,000 |
29,950 |
36,500 |
| Zaderej Karen L. | Director |
May 16 '25 |
Buy |
5.81 |
5,000 |
29,050 |
31,500 |
| Zaderej Karen L. | Director |
May 15 '25 |
Buy |
5.47 |
5,000 |
27,350 |
26,500 |
| Zaderej Karen L. | Director |
May 14 '25 |
Buy |
5.42 |
5,000 |
27,100 |
21,500 |
| Elston George | Chief Financial Officer |
Feb 09 '25 |
Option Exercise |
0.00 |
5,834 |
0 |
75,550 |
| Lurker Nancy | Director |
Feb 09 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
205,436 |
| Duker Jay S. | President and CEO |
Feb 09 '25 |
Option Exercise |
0.00 |
7,000 |
0 |
79,706 |
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):